Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 1
1966 1
1968 2
1972 1
1974 3
1976 1
1977 2
1983 1
1992 1
2001 1
2002 1
2003 18
2004 3
2005 4
2007 3
2008 7
2009 2
2010 3
2011 1
2013 3
2014 3
2015 4
2016 2
2017 2
2018 3
2019 4
2020 4
2021 54
2022 189
2023 119
2024 33

Text availability

Article attribute

Article type

Publication date

Search Results

438 results

Results by year

Filters applied: . Clear all
Page 1
The Aftermath of COVID-19: Exploring the Long-Term Effects on Organ Systems.
Golzardi M, Hromić-Jahjefendić A, Šutković J, Aydin O, Ünal-Aydın P, Bećirević T, Redwan EM, Rubio-Casillas A, Uversky VN. Golzardi M, et al. Biomedicines. 2024 Apr 20;12(4):913. doi: 10.3390/biomedicines12040913. Biomedicines. 2024. PMID: 38672267 Free PMC article. Review.
Previous studies have shown that PASC impacts 10% of SARS-CoV-2 infected patients of which 50-70% are hospitalised. It has also been shown that 10-12% of those vaccinated against COVID-19 were affected by PASC and its complications. ...The cardiovascular system also has be …
Previous studies have shown that PASC impacts 10% of SARS-CoV-2 infected patients of which 50-70% are hospitalised. It has also been shown t …
Safety of Ancestral Monovalent BNT162b2, mRNA-1273, and NVX-CoV2373 COVID-19 Vaccines in US Children Aged 6 Months to 17 Years.
Hu M, Shoaibi A, Feng Y, Lloyd PC, Wong HL, Smith ER, Amend KL, Kline A, Beachler DC, Gruber JF, Mitra M, Seeger JD, Harris C, Secora A, Obidi J, Wang J, Song J, McMahill-Walraven CN, Reich C, McEvoy R, Do R, Chillarige Y, Clifford R, Cooper DD, Forshee RA, Anderson SA. Hu M, et al. JAMA Netw Open. 2024 Apr 1;7(4):e248192. doi: 10.1001/jamanetworkopen.2024.8192. JAMA Netw Open. 2024. PMID: 38656578 Free PMC article.
Thirteen of 15 sequentially tested outcomes did not meet the threshold for a statistical signal. Statistical signals were detected for myocarditis or pericarditis after BNT162b2 vaccination in children aged 12 to 17 years and seizure after vaccination …
Thirteen of 15 sequentially tested outcomes did not meet the threshold for a statistical signal. Statistical signals were detected for my …
Comparative safety profile of bivalent and original COVID-19 mRNA vaccines regarding myocarditis/pericarditis: A pharmacovigilance study.
Chen C, Chen C, Cao L, Fang J, Xiao J. Chen C, et al. Int Immunopharmacol. 2024 Apr 13;133:112022. doi: 10.1016/j.intimp.2024.112022. Online ahead of print. Int Immunopharmacol. 2024. PMID: 38615382 Free article.
This study aimed to investigate the risk of myocarditis/pericarditis following bivalent COVID-19 mRNA vaccination compared to monovalent vaccination. ...Disproportionality analysis revealed a higher reporting of myocarditis/pericarditis f …
This study aimed to investigate the risk of myocarditis/pericarditis following bivalent COVID-19 mRNA vaccination compa …
Characterization of Brighton Collaboration criteria for myocarditis and pericarditis following COVID-19 vaccine in Korean adolescents.
Lee JS, Choi H, Shin SH, Hwang MJ, Na S, Kim JH, Park S, Yoon Y, Kang HM, Ahn B, Seo K, Choe YJ. Lee JS, et al. Vaccine. 2024 Apr 11:S0264-410X(24)00446-8. doi: 10.1016/j.vaccine.2024.04.032. Online ahead of print. Vaccine. 2024. PMID: 38604914
BACKGROUND: Vaccines are vital for public health, but concerns about adverse effects, particularly myocarditis and pericarditis linked to COVID-19 vaccines-, persist. ...METHODS: This study analyzed 190 medical records of individuals who claimed to hav …
BACKGROUND: Vaccines are vital for public health, but concerns about adverse effects, particularly myocarditis and pericard …
Myocarditis, Coagulopathy, and Small Fibre, Sensory, and Multiple Cranial Nerve Neuropathy Complicating BNT162b2 Vaccination: A Case Report.
Finsterer J. Finsterer J. Cureus. 2024 Feb 29;16(2):e55205. doi: 10.7759/cureus.55205. eCollection 2024 Feb. Cureus. 2024. PMID: 38558730 Free PMC article.
SARS-CoV-2 vaccinations can lead to complications, including post-acute COVID-19 vaccination syndrome (PACVS). There has been no report of a patient with PACVS presenting with Guillain-Barre syndrome (GBS), myocarditis/pericarditis, immunodeficiency, o …
SARS-CoV-2 vaccinations can lead to complications, including post-acute COVID-19 vaccination syndrome (PACVS). There has been …
A Pragmatic Study of Cardiovascular Disease During Long-Term COVID-19.
Howick JF 5th, Saric P, Elwazir M, Newman DB, Pellikka PA, Howick AS, O'Horo JC, Cooper LT Jr, Deshmukh AJ, Ganesh R, Hurt R, Gersh B, Bois JP. Howick JF 5th, et al. Am J Med. 2024 Mar 26:S0002-9343(24)00162-1. doi: 10.1016/j.amjmed.2024.03.011. Online ahead of print. Am J Med. 2024. PMID: 38548213
RESULTS: Among 40,462 unique patients diagnosed with COVID-19 at our tertiary referral center from April 2020 to March 2022, 363 (0.9%) patients with long COVID were evaluated by Cardiology for possible cardiac sequelae from COVID and formed the main study cohort. Of these, 229 ( …
RESULTS: Among 40,462 unique patients diagnosed with COVID-19 at our tertiary referral center from April 2020 to March 2022, 363 (0.9%) pati …
Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination: 2024 Status and Management Update.
McDonald MA, Kafil TS, Khoury M, Luk AC, Wright MK, Hawkins NM. McDonald MA, et al. Can J Cardiol. 2024 Mar 25:S0828-282X(24)00277-0. doi: 10.1016/j.cjca.2024.03.016. Online ahead of print. Can J Cardiol. 2024. PMID: 38537672 Free article.
In this brief review, we summarize new evidence about the epidemiology and outcomes of patients with mRNA COVID-19 post-vaccine myocarditis and pericarditis. We also provide consensus guidance for evaluation, management, and follow-up. Finally, we identify pe …
In this brief review, we summarize new evidence about the epidemiology and outcomes of patients with mRNA COVID-19 post-vaccine my …
Global Safety Assessment of Adverse Events of Special Interest Following 2 Years of Use and 772 Million Administered Doses of mRNA-1273.
Urdaneta V, Esposito DB, Dharia P, Moraga MS, Anteyi K, Oduyebo-Omotosho T, Rossi M, Burton P, Vega JM, Dawson R, Straus W. Urdaneta V, et al. Open Forum Infect Dis. 2024 Feb 2;11(3):ofae067. doi: 10.1093/ofid/ofae067. eCollection 2024 Mar. Open Forum Infect Dis. 2024. PMID: 38500575 Free PMC article.
AESIs represented 13.7% of all AEs (344 921/2 517 669), with reporting rates for most AESIs below the expected background incidence. Exceptions included anaphylaxis (OE ratio 3 days after vaccination, 2.09; 95% CI, 1.93-2.25) and, among individuals aged 12 to 40 years, …
AESIs represented 13.7% of all AEs (344 921/2 517 669), with reporting rates for most AESIs below the expected background incidence. Excepti …
Benefit-risk assessment for the Novavax COVID-19 vaccine (NVX-CoV2373).
Fix J, Christopher Mast T, Smith K, Baker N. Fix J, et al. Vaccine. 2024 Apr 2;42(9):2161-2165. doi: 10.1016/j.vaccine.2024.03.036. Epub 2024 Mar 16. Vaccine. 2024. PMID: 38494410 Free article.
A benefit-risk assessment of NVX-CoV2373, a vaccine to prevent COVID-19, was conducted to determine if the benefits of vaccination outweigh the risks of myocarditis/pericarditis. ...The risks of myocarditis/pericarditis cases and related …
A benefit-risk assessment of NVX-CoV2373, a vaccine to prevent COVID-19, was conducted to determine if the benefits of vaccination …
438 results